CD163L1 | CD163 molecule-like 1 | CD markers Predicted intracellular proteins Predicted membrane proteins
| | ![](/images/15663/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/15663/34961_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
CD226 | CD226 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/15715/37859_A_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
CD300LF | CD300 molecule-like family member f | CD markers Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13712/117004_B_9_8_rna_selected_60x60.jpg) | Tissue enhanced |
CD37 | CD37 molecule | CD markers Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/2492/6131_A_2_6_rna_selected_60x60.jpg) | Tissue enhanced |
CD7 | CD7 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/39079/134055_A_2_5_selected_60x60.jpg) | ![](/images/2594/6570_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
CD79A | CD79a molecule, immunoglobulin-associated alpha | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/19/395_A_8_8_rna_selected_60x60.jpg) | Tissue enhanced |
CD8A | CD8a molecule | CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/37756/ihc_cell_selected_60x60.jpg) | ![](/images/12/106_B_1_7_rna_selected_60x60.jpg) | Tissue enhanced |
CR1 | Complement component (3b/4b) receptor 1 (Knops blood group) | Blood group antigen proteins CD markers Plasma proteins Predicted membrane proteins
| | ![](/images/42455/if_selected_60x60.jpg) | ![](/images/2491/ihc_cell_selected_60x60.jpg) | ![](/images/2491/6134_B_1_3_rna_selected_60x60.jpg) | Tissue enhanced |
FCRL1 | Fc receptor-like 1 | CD markers Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13323/30968_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
GP9 | Glycoprotein IX (platelet) | CD markers Disease related genes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/63182/142047_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
HIST2H3PS2 | Histone cluster 2, H3, pseudogene 2 | Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42570/103605_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
HMHA1 | Histocompatibility (minor) HA-1 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/19816/45222_A_8_7_rna_selected_60x60.jpg) | Tissue enhanced |
IGSF21 | Immunoglobin superfamily, member 21 | Predicted intracellular proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/44535/99160_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
IL2RB | Interleukin 2 receptor, beta | Cancer-related genes CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | ![](/images/51627/1040_F6_2_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/62657/139409_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
ITGAL | Integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) | CD markers FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/25011/57822_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
ITGAX | Integrin, alpha X (complement component 3 receptor 4 subunit) | CD markers Predicted membrane proteins Predicted secreted proteins
| | ![](/images/4723/if_selected_60x60.jpg) | | ![](/images/4458/14041_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
KLRC3 | Killer cell lectin-like receptor subfamily C, member 3 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/62570/146083_B_7_3_rna_selected_60x60.jpg) | Tissue enhanced |
KLRK1 | Killer cell lectin-like receptor subfamily K, member 1 | Cancer-related genes CD markers Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/21896/49187_B_9_4_rna_selected_60x60.jpg) | Tissue enhanced |
LAG3 | Lymphocyte-activation gene 3 | CD markers Predicted membrane proteins Predicted secreted proteins
| | ![](/images/2301/if_selected_60x60.jpg) | | ![](/images/13967/30400_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
MYO1F | Myosin IF | Plasma proteins Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/55242/131722_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
NCF1 | Neutrophil cytosolic factor 1 | Disease related genes Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | | ![](/images/47836/129864_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
NKG2-E | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000437563} | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/62570/146083_B_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
P2RY13 | Purinergic receptor P2Y, G-protein coupled, 13 | G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/49047/111260_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
PF4V1 | Platelet factor 4 variant 1 | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/52485/126145_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
PITPNM3 | PITPNM family member 3 | Disease related genes Predicted intracellular proteins
| | ![](/images/59005/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/22432/133053_B_2_1_rna_selected_60x60.jpg) | Tissue enhanced |
PSTPIP2 | Proline-serine-threonine phosphatase interacting protein 2 | Cytoskeleton related proteins Predicted intracellular proteins
| | ![](/images/40923/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/40944/90010_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
PTPRCAP | Protein tyrosine phosphatase, receptor type, C-associated protein | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/43734/97692_A_7_1_rna_selected_60x60.jpg) | Tissue enhanced |
RENBP | Renin binding protein | Enzymes Predicted intracellular proteins
| | | | ![](/images/522/904_A_1_7_rna_selected_60x60.jpg) | Tissue enhanced |
SCIMP | SLP adaptor and CSK interacting membrane protein | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/6117/19046_A_9_5_rna_selected_60x60.jpg) | Tissue enhanced |
SEPT1 | Septin 1 | Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | | ![](/images/41566/89971_A_7_6_rna_selected_60x60.jpg) | Tissue enhanced |
SIGLEC14 | Sialic acid binding Ig-like lectin 14 | Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14377/33569_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
SLC9A5 | Solute carrier family 9, subfamily A (NHE5, cation proton antiporter 5), member 5 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | ![](/images/41329/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/41004/90176_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
TBC1D10C | TBC1 domain family, member 10C | Predicted intracellular proteins Predicted membrane proteins
| | ![](/images/69743/1414_A7_2_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/69743/153255_A_7_3_rna_selected_60x60.jpg) | Tissue enhanced |
TBX21 | T-box 21 | Disease related genes Predicted intracellular proteins Transcription factors
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/30043/70681_A_7_1_rna_selected_60x60.jpg) | Tissue enhanced |
VCAM1 | Vascular cell adhesion molecule 1 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/5426/18356_B_9_4_rna_selected_60x60.jpg) | Tissue enhanced |
WAS | Wiskott-Aldrich syndrome | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | ![](/images/2022/7422_A_8_1_rna_selected_60x60.jpg) | Tissue enhanced |